GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Binex Co Ltd (XKRX:053030) » Definitions » ROE % Adjusted to Book Value

Binex Co (XKRX:053030) ROE % Adjusted to Book Value : -5.96% (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Binex Co ROE % Adjusted to Book Value?

Binex Co's ROE % for the quarter that ended in Sep. 2024 was -26.63%. Binex Co's PB Ratio for the quarter that ended in Sep. 2024 was 4.47. Binex Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was -5.96%.


Binex Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Binex Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binex Co ROE % Adjusted to Book Value Chart

Binex Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.56 0.80 4.14 3.60 1.64

Binex Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.53 2.49 -7.90 -4.82 -5.96

Competitive Comparison of Binex Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Binex Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Binex Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Binex Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Binex Co's ROE % Adjusted to Book Value falls into.



Binex Co ROE % Adjusted to Book Value Calculation

Binex Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.51% / 1.53
=1.64%

Binex Co's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-26.63% / 4.47
=-5.96%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Binex Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Binex Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Binex Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
480-2 Janglim-dong, Saha-gu, Busan, KOR, 604-846
Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.

Binex Co Headlines

No Headlines